Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction

Heart Rhythm Research Laboratory, Division of Cardiology, Oregon Health and Science University, Portland, Oregon.
Journal of the American College of Cardiology (Impact Factor: 15.34). 03/2006; 47(6):1161-6. DOI: 10.1016/j.jacc.2005.11.045
Source: PubMed

ABSTRACT We sought to evaluate the contribution of left ventricular (LV) dysfunction toward occurrence of sudden cardiac death (SCD) in the general population, and to identify distinguishing characteristics of SCD in the absence of LV dysfunction.
Patients who manifest warning symptoms and signs are more likely to undergo evaluation before SCD. Although prevalence of LV dysfunction in this subgroup may overestimate the prevalence in overall SCD, this is the only means of assessment in the general population.
All cases of SCD in Multnomah County, Oregon (population 660,486; 2002 to 2004) were prospectively ascertained in the ongoing Oregon Sudden Unexpected Death Study. We retrospectively assessed LV ejection fraction (LVEF) among subjects who underwent evaluation of LV function before SCD (normal: > or =55%; mildly to moderately reduced: 36% to 54%; and severely reduced: < or =35%). Of a total of 714 SCD cases (annual incidence 54 per 100,000), LV function was assessed in 121 (17%).
The LVEF was severely reduced in 36 patients (30%), mildly to moderately reduced in 27 (22%), and normal in 58 (48%). Patients with normal LVEF were distinguishable by younger age (66 +/- 15 years vs. 74 +/- 10 years; p = 0.001), higher proportion of females (47% vs. 27%; p = 0.025), higher prevalence of seizure disorder (14% vs. 0%; p = 0.002), and lower prevalence of established coronary artery disease (50% vs. 81%; p < 0.001).
In this community-wide study, only one-third of the evaluated SCD cases had severe LV dysfunction meeting current criteria for prophylactic cardioverter-defibrillator implantation. The SCD cases with normal LV function had several distinguishing clinical characteristics. These findings support the aggressive development of alternative screening methods to enhance identification of patients at risk.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Current guidelines for the primary prevention of sudden cardiac death have used a left ventricular ejection fraction (LVEF) ≤35% as a critical point to justify implantable cardioverter defibrillator (ICD) implantation in post myocardial infarction patients and in those with nonischemic dilated cardiomyopathy. We compared mortality and ICD activation rates among different ICD group recipients using a cut-off value for LVEF ≤35%. METHODS: We followed up for a mean period of 41.1months 495 ICD recipients (442 males, 65.6years old, 68.9% post myocardial infarction patients, 422 with LVEF≤35%). Prevention was considered primary in patients who fulfilled guidelines criteria or had inducible ventricular arrhythmia during programmed ventricular stimulation for patients with LVEF >35%. RESULTS: Over the course of the trial, 84 of 495 patients died; 69 experienced cardiac death (6 sudden) and 15 non cardiac death. ICD recipients with LVEF ≤35% compared to those with preserved LVEF (mean LVEF=43%) had a greater incidence of total mortality (18% vs. 11%, log rank p=0.028) and cardiac death (15.4% vs. 5.5%, log rank p=0.005). There was no difference in the incidence for appropriate device therapy between patients with LVEF ≤35% and those with LVEF >35% (56.9% vs. 65.8%, log rank p=0.93). In the multivariate analysis the presence of advanced New York Heart Association stage predicted both total mortality (HR=2.69, 95% CI 1.771-4.086) and cardiac death (HR=3.437, 95% CI 2.163-5.463). CONCLUSIONS: ICD therapy may protect heart failure patients at early stages from arrhythmic morbidity and mortality, based on an electrophysiology-guided risk stratification approach.
    International journal of cardiology 04/2012; 167(4). DOI:10.1016/j.ijcard.2012.04.005
  • Source
    Cardiac Defibrillation - Prediction, Prevention and Management of Cardiovascular Arrhythmic Events, 11/2011; , ISBN: 978-953-307-692-8
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The CARTO XP ablation system provides real-time data on 3D, color-coded maps of the electrical activity of the heart; however, it is expensive and can only use a dedicated costly magnetic catheter per patient intervention. The purpose of our study is to shorten the duration of the radiofrequency ablation procedure and increase its efficacy by developing an affordable prototype catheter navigation system that simulates the CARTO system. To obtain 3D geometrical data from catheter locations inside the heart chamber, we acquired only single-view images using an Integris Allura fluoroscope and estimated the depth of the mapping electrode using pattern recognition techniques. Validation was performed in ideal and clinical conditions. For phantom experiment, when using a 7-French catheter, the average recovered depth error was 2.05 ± 1.46 mm using a single image. However, when using the 8-French catheter, the average recovered depth error was 1.54 ± 1.29 mm. In clinical experimentation, the standard error of estimate for the estimated depth was about 13.1 mm and 10.1 mm, respectively, for the posterior and lateral views. In conclusion, this paper describes our achievements and shortfalls in developing an affordable fluoroscopic navigation system to guide RF catheter ablation of cardiac arrhythmias.
    International Journal of Biomedical Imaging 03/2010; 2010:1. DOI:10.1155/2010/631264


Available from